You are viewing an inactive listing

Burlington, Vermont 05401

  • Related Disorders

Purpose:

The purpose of this study is to test combined buprenorphine and behavioral treatment with and without contingent reinforcement on opioid and cocaine abstinence.


Criteria:

Please contact site for information.


Study is Available At:


Original ID:

NIDA-06969-22


NCT ID:

NCT00000240


Secondary ID:

R01DA006969


Study Acronym:


Brief Title:

Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22


Official Title:

Combined Buprenorphine and Behavioral Treatment Without Contingent Reinforcement


Overall Status:

Completed


Study Phase:

Phase 2


Genders:

Both


Minimum Age:

23 Years


Maximum Age:

47 Years


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

University of Vermont


Oversight Authority:

United States: Federal Government


Reasons Why Stopped:


Study Type:

Interventional


Study Design:

Masking: Open Label, Primary Purpose: Treatment


Number of Arms:

0


Number of Groups:

0


Total Enrollment:

0


Enrollment Type:


Overall Contact Information

Official Name:Warren Bickel, Ph.D.
Principal Investigator
University of Vermont

Study Dates

Start Date:April 1999
Verification Date:April 1999
Last Changed Date:June 2, 2015
First Received Date:September 20, 1999

Study Outcomes

Outcome Type:Primary Outcome
Measure:Drug use
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Retention
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Weeks abstinent
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Weeks continuous abstinence
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Overall treatment outcome
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Opioid dependence and psychiatric status
Safety Issues:False

Study Interventions

Intervention Type:Drug
Name:Buprenorphine

Study Arms

There are no available Study Arms

Study Agencies

Agency Class:Other
Agency Type:Lead Sponsor
Agency Name:University of Vermont
Agency Class:NIH
Agency Type:Collaborator
Agency Name:National Institute on Drug Abuse (NIDA)

Sample and Retention Information

There are no available Sample and Retention Information

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: July 25, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


This study is not currently recruiting Study Participants. The form below is not enabled.